The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes

NCT06408532 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

256

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: IDegLira
DRUG: Premixed insulin

Sponsor

Peking University People's Hospital